This inventor holds 2 USPTO granted patents. Top assignee: Warner-Lambert Company. Active years: 2001-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2003
Title: Innovations of Kenneth Earl Mennen
Introduction
Kenneth Earl Mennen is a notable inventor based in Holland, MI (US). He has made significant contributions to the field of chemistry, particularly in the development of anticonvulsant compounds. With a total of 2 patents, Mennen's work has had a meaningful impact on pharmaceutical innovations.
Latest Patents
Mennen's latest patents include a process for preparing a cyclic amino acid anticonvulsant compound. This innovative synthesis involves treating benzonitrile with an alkali metal and an amine under Birch reduction conditions. This method generates an anionic intermediate in situ, which is then alkylated with an α-haloacetic acid moiety. The process ultimately leads to the desired product and valuable intermediates used in the synthesis.
Career Highlights
Kenneth Earl Mennen has been associated with Warner-Lambert Company, where he has applied his expertise in chemistry to advance pharmaceutical research. His work has contributed to the development of new medications that can improve patient outcomes.
Collaborations
Mennen has collaborated with notable colleagues such as Carl F. Deering and Robert Ramage. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Kenneth Earl Mennen's contributions to the field of chemistry and his innovative patents highlight his role as a significant inventor. His work continues to influence the development of anticonvulsant compounds, showcasing the importance of innovation in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile